← All trials
NCT05633433
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 15, 2022
- Primary completion
- Jun 15, 2024
- Completion date
- Jul 15, 2024
- First posted
- Dec 1, 2022
- Last posted
- Dec 1, 2022
- Enrollment
- 1550
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Shanghai Henlius BiotechLead sponsor
- HeNan Sincere Biotech Co., LtdCollaborator
- FosunCollaborator
- Government of ChinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.